BioCentury
ARTICLE | Financial News

Aug. 7 Financial Quick Takes: Allakos raises $350M; plus Exicure

August 8, 2019 12:51 AM UTC

Allakos raises $350M in upsized follow-on
Allakos Inc. (NASDAQ:ALLK) added $8.03 (10%) to $87.50 Wednesday after raising $350 million through the sale of 4.5 million shares at $77 in a bumped-up follow-on. The company had proposed Monday to raise $200 million after more than doubling its value on the back of data showing that its AK002 met the primary endpoint in a Phase II study to treat eosinophilic GI disorders (see "Big Gain for Allakos")...

BCIQ Company Profiles

Allakos Inc.

Exicure Inc.